Acute promyelocytic leukemia presenting as recurrent venous and arterial thrombotic events: a case report and review of the literature

References

• de Thé H, Le Bras M, Lallemand-Breitenbach V. The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. J Cell Biol. 2012 Jul 9;198(1):11–21.
   Web of Science ®Google Scholar
• Park J, Jurcic JG, Rosenblat T, et al. Emerging new approaches for the treatment of acute promyelocytic leukemia. Ther Adv Hematol. 2011 Oct;2(5):335–352.
   PubMedGoogle Scholar
• Saeed S, Logie C, Stunnenberg HG, et al. Genome-wide functions of PML-RARα in acute promyelocytic leukaemia. Br J Cancer. 2011 Feb 15;104(4):554–558.
   PubMed Web of Science ®Google Scholar
• Brown NJ, Ramalho M, Pedersen EW, et al. PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders? Front Biosci (Landmark Ed). 2009 Jan 1;14(14):1684–1707.
   Google Scholar
• LK HILLESTAD. Acute promyelocytic leukemia. Acta Med Scand. 1957 Nov;159(3):189–194.
   Google Scholar
• Mitrovic M, Suvajdzic N, Elezovic I, et al. Thrombotic events in acute promyelocytic leukemia. Thromb Res. 2015 Apr;135(4):588–593.
   Web of Science ®Google Scholar
• De Stefano V, Sorà F, Rossi E, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost. 2005 Sep;3(9):1985–1992.
   PubMed Web of Science ®Google Scholar
• Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013 Jul;369(2):111–121.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang Y, Yang H, et al. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia. Hematology. 2018 Dec;23(10):756–764.
   Web of Science ®Google Scholar
• Menell JS, Cesarman GM, Jacovina AT, et al. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med. 1999 Apr;340(13):994–1004.
   PubMed Web of Science ®Google Scholar
• Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem. 1994 Aug;269(33):21198–21203.
   PubMed Web of Science ®Google Scholar
• Barbui T, Finazzi G, Falanga A. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood. 1998 May;91(9):3093–3102.
   PubMed Web of Science ®Google Scholar
• Egbring R, Schmidt W, Fuchs G, et al. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood. 1977 Feb;49(2):219–231.
   Web of Science ®Google Scholar
• Wilcox JN, Smith KM, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2839–2843.
   PubMed Web of Science ®Google Scholar
• Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry. 1990 Oct 9;29(40):9418–9425.
   PubMed Web of Science ®Google Scholar
• Zhu J, Guo WM, Yao YY, et al. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia. 1999 Jul;13(7):1062–1070.
   Web of Science ®Google Scholar
• Falanga A, Barbui T. Coagulopathy of acute promyelocytic leukemia. Acta Haematol. 2001;106(1–2):43–51.
   Web of Science ®Google Scholar
• Barbui T, Falanga A. Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost. 2001 Dec;27(6):593–604.
   PubMed Web of Science ®Google Scholar
• Arbuthnot C, Wilde JT. Haemostatic problems in acute promyelocytic leukaemia. Blood Rev. 2006 Nov;20(6):289–297.
   Web of Science ®Google Scholar
• Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood. 1992 Feb;79(3):543–553.
   PubMed Web of Science ®Google Scholar
• Stone RM, Mayer RJ. The unique aspects of acute promyelocytic leukemia. J Clin Oncol. 1990 Nov;8(11):1913–1921.
   PubMed Web of Science ®Google Scholar
• Runde V, Aul C, Heyll A, et al. All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia. Blood. 1992 Jan;79(2):534–535.
   PubMed Web of Science ®Google Scholar
• Bombeli T, Karsan A, Tait JF, et al. Apoptotic vascular endothelial cells become procoagulant. Blood. 1997 Apr;89(7):2429–2442.
   PubMed Web of Science ®Google Scholar
• Cao M, Li T, He Z, et al. Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia. Blood. 2017 Mar 30;129(13):1855–1864.
   Web of Science ®Google Scholar
• Breccia M, Avvisati G, Latagliata R, et al. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia. 2007 Jan;21(1):79–83.
   PubMed Web of Science ®Google Scholar
• Candelpergher G, Suzzi GL, Visonà A, et al. [Acute myocardial infarct as the first manifestation of acute myeloid leukemia. Description of an anatomo-clinical case]. G Ital Cardiol. 1980;10(10):1403–1407.
   Google Scholar
• Hd S, Stanley A, Pc K, et al. Acute promyelocytic leukaemia associated with acute myocardial infarction A case report. S Afr Med J. 1986 July;70(2):117–118.
   Web of Science ®Google Scholar
• Quadir TA, Dhabhar BN, Dhar AK, et al. Acute promyelocytic leukemia with ischaemic events. J Assoc Physicians India. 1993 May;41(5):300–302.
   Google Scholar
• Lou Y, Mai W, Jin J. Simultaneous presentation of acute myocardial infarction and acute promyelocytic leukemia. Ann Hematol. 2006 Jun;85(6):409–410.
   Web of Science ®Google Scholar
• Altwegg SC, Altwegg LA, Maier W. Intracoronary thrombus with tissue factor expression heralding acute promyelocytic leukaemia. Eur Heart J. 2007 Nov;28(22):2731.
   Web of Science ®Google Scholar
• Cahill TJ, Chowdhury O, Myerson SG, et al. Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging. Circulation. 2011 Mar;123(10):e370–2.
   Web of Science ®Google Scholar
• Sargsyan Z, Higgins C, Alexandrescu S, et al. Acute promyelocytic leukemia as a cause of intracoronary drug-eluting-stent thrombosis. Tex Heart Inst J. 2012;39(3):416–419.
   Web of Science ®Google Scholar
• Thomas TO, Ramachandran P, Jefferies JL, et al. Prompt recognition and percutaneous coronary intervention leads to favorable myocardial recovery after ST-segment elevation myocardial infarction secondary to acute promyelocytic leukemia: pediatric case report. Pediatr Cardiol. 2013;34(8):2047–2051.
   Web of Science ®Google Scholar
• Li Y, Suo S, Mao L, et al. Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient. Int J Clin Exp Med. 2015;8(8):14210–14213.
   Web of Science ®Google Scholar
• Jetha N. Promyelocytic leukemia with multiorgan infarctions and large-vessel thrombosis. Arch Pathol Lab Med. 1981 Dec;105(12):683–684.
   Web of Science ®Google Scholar
• Fass R, Haddad M, Zaizov R, et al. Recurrent peripheral arterial occlusion by leukemic cells sedimentation in acute promyelocytic leukemia. J Pediatr Surg. 1992 May;27(5):665–667.
   Web of Science ®Google Scholar
• Rolston DD, Rubin S, Topolsky D, et al. Arterial occlusions as a presenting feature of acute promyelocytic leukemia. Am J Clin Oncol. 1998 Oct;21(5):436–437.
   Web of Science ®Google Scholar
• DiGiovanni RJ, Crilley P, Kerstein MD. Peripheral arterial occlusion in acute promyelocytic leukemia. Cardiovasc Surg. 1999 Mar;7(2):21198–21203.
   Google Scholar
• Kalk E, Goede A, Rose P. Acute arterial thrombosis in acute promyelocytic leukaemia. Clin Lab Haematol. 2003 Aug;25(4):267–270.
   Google Scholar
• Posacioglu H, Apaydin A, Buyukkececi F, et al. Recurrent Peripheral Arterial Occlusion in Acute Promyelocytic Leukemia. EJVES Extra. 2003;6(5):100–102.
   Google Scholar
• Belizna C, Pistorius MA, Planchon B. Lethal limb ischaemia in leukaemia. Case report and review of the literature. J Thromb Thrombolysis. 2009 Oct;28(3):354–357.
   Web of Science ®Google Scholar
• Chotai PN, Kasangana K, Chandra AB, et al. Recurrent Arterial Thrombosis as a Presenting Feature of a Variant M3-Acute Promyelocytic Leukemia. Vasc Specialist Int. 2016 Jun;32(2):65–71.
   Google Scholar
• Chavez MA, Heidari B, Thacker S, et al. Acute Promyelocytic Leukemia Presenting as Bilateral Acute Limb Ischemia and ST Elevation Myocardial Infarction: a Case Report. Cureus. 2020 Jun;12(6):e8495.
   PubMed Web of Science ®Google Scholar
• Carella AM, Antonucci G, Conte M, et al. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment. Cardiovasc Hematol Disord Drug Targets. 2010 Mar;10(1):1–6.
   Google Scholar
• Kapoor R, Pati HP, Gupta SK, et al. Acute promyelocytic leukemia presenting as ischemic stroke in young. Indian J Hematol Blood Transfus. 2013 Jun;29(2):93–95.
   Web of Science ®Google Scholar
• Kishore M, Kumar V, Marwah S, et al. Unusual Presentation of Acute Leukaemia: a Tripod of Cases. J Clin Diagn Res. 2016 Oct;10(10):ED04–ED08.
   Web of Science ®Google Scholar
• Trottier-Tellier F, Durand M, Kolan C, et al. Recurrent arterial and venous thromboemboli as initial presentation of acute promyelocytic leukemia. J Clin Med Res. 2014 Oct;6(5):388–391.
   Google Scholar
• Vaid AK, Batra S, Karanth SS, et al. Acute promyelocytic leukemia presenting as pulmonary thromboembolism: not all APLs bleed. Avicenna J Med. 2015 Oct-Dec;5(4):131–133.
   Google Scholar
• Jandial A, Mishra K, Lad D, et al. Deluging thrombosis: an unusual presentation of acute promyelocytic leukemia. Indian Journal of Medical and Paediatric Oncology. 2020;41(2):282–284.
   Web of Science ®Google Scholar
• Bandyopadhyay S, Bandyopadhyay D. Acute Budd-Chiari syndrome as an initial presentation of acute promyelocytic leukemia. J Cancer Res Ther. 2010 Oct-Dec;6(4):567–569.
   Web of Science ®Google Scholar